Arizona Tribune - Boulevard

Jailed Thai ex-PM Thaksin requests royal pardon: lawyer

Thailand's influential former prime minister Thaksin Shinawatra has applied for a royal pardon to reduce his one-year prison sentence, his lawyer told reporters on Monday.

Typhoon Bualoi kills dozens in Vietnam and Philippines

A typhoon that ripped roofs off homes has killed dozens of people across Vietnam and the Philippines, officials from both countries said on Monday, as a weakened storm Bualoi crossed into neighbouring Laos.

Gunman kills four in attack on northern US Mormon church

A man opened fire in a Mormon church in Michigan and set the building ablaze on Sunday, killing at least four people in the latest deadly tragedy that US President Donald Trump called part of a national "epidemic of violence."

'Predators': how reality TV explains Epstein obsession

As demands to release the so-called Epstein files rage on, a new documentary asks why America is so fascinated with child sex abusers by reflecting on the salacious 2000s reality TV series "To Catch A Predator."

Air France, Airbus back on trial over doomed 2009 Rio flight

An appeals trial of Air France and Airbus opens Monday over the 2009 crash of a Rio-Paris flight that killed 228 people, the worst disaster in the French flag carrier's history.

Four killed in attack on northern US Mormon church

At least four people were killed and several others wounded Sunday after a shooter targeted a Mormon church in Michigan, authorities said, in the latest deadly tragedy that US President Donald Trump called part of a national "epidemic of violence."

Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

KELOWNA, BC / ACCESS Newswire / September 29, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 2,666,667 shares of its common stock, par value $0.001 per share, at a purchase price of $1.50 per share. In addition, in a concurrent private placement, the Company issued unregistered warrants to purchase up to 2,666,667 shares of common stock. The warrants have an exercise price of $1.37 per share, are immediately exercisable and expire five years from the date of the effectiveness of the resale registration statement registering the shares of common stock issuable upon exercise of the unregistered warrants.

Brenmiller Signs System Purchase Agreement with Baran Energy for bGen ZERO Systems at Tempo Beverages and Wolfson Medical Center

Brenmiller to receive milestone-based payments for the sale of the bGen systems, profit sharing from future income generated on the projects, and maintenance and operations service revenueTransaction provides non-dilutive capital injection as part of capital-efficient growth strategy, powering Brenmiller to advance its broader global project pipeline of commercial opportunities valued at over $500 millionMilestone marks a significant evolution in the relationship between Brenmiller and Baran following the signing of a strategic collaboration agreement in February 2025

Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes

ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan to conduct an Institutional Review Board (IRB) study that could fundamentally transform the cannabinoid edible and nutraceutical markets.

Fortified Health Security Acquires Latitude, Expands Cybersecurity Advisory Capabilities

BRENTWOOD, TN / ACCESS Newswire / September 29, 2025 / Fortified Health Security (Fortified), a Best in KLAS managed security services provider (MSSP) specializing in healthcare cybersecurity, today announced its acquisition of Latitude Information Security (Latitude), a healthcare-focused cybersecurity advisory firm known for its expertise in HITRUST CSF, risk assessments and third-party risk management.

Miracle CEO Defeats Cancer and Leads Medical AI Innovation at (OTC PINK:MDCE) Medical Care Technologies Inc.

MESA, AZ / ACCESS Newswire / September 29, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announces a new era of leadership and innovation under CEO Marshall Perkins, whose extraordinary personal journey is now fueling the company's mission to transform healthcare.

dHealth Intelligence Launches Revolutionary AI Agent That Transforms Personal Healthcare Management

ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2025 / Healthcare AI startup dHealth Intelligence just unveiled an AI agent that consolidates fragmented medical data & provides advice based on it, while protecting patient privacy. Available now as a free desktop download, the platform transforms scattered medical records, fitness data, and doctor's notes into a unified health narrative through simple user commands. It also provides fully private AI medical consultations. Mobile versions arrive Q1 2026. Follow development updates @dHealth_Network.

P-n-T Data Corp. Announces Full Board of Directors and Executive Leadership Team

Leadership depth reinforces the company's mission to modernize healthcare data sharing with speed, security, and control

RMTG Partners with BKFC as Official Regenerative Medicine Provider

Combat Sports Partnership Brings Advanced Stem Cell Treatments to Elite Fighters

Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry

Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue.Nine-episode inaugural season hosted by industry thought leader Melissa K. Turner, BASDH, RDHEP, EFDA, CHO.Candid conversations with leading clinicians on the trends shaping today's dental landscape.Episodes launch on September 29 on major podcast platforms; register now at oratalks.com for episode alerts and exclusive updates.

Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds

SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market, today announced the exercise of certain existing warrants issued in May 2023 and March 2025 (the "Existing Warrants") at a reduced exercise price of $0.68 per share. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to effective registration statements on Form S-1 (file no. 333-271413), as amended, and Form S-3 (file no. 333-286768).

Avant Brands Recognized as One of Canada's Top Growing Companies by The Globe and Mail for Third Consecutive Year

KELOWNA, B.C. / ACCESS Newswire / September 29, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today announced it has been recognized as one of Canada's Top Growing Companies in The Globe and Mail's 2025 Report on Business. This marks the third consecutive year Avant has earned a place on the list, ranking 138th with three-year revenue growth of 263%. Avant previously ranked #49 in 2023 and #182 in 2024.

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the skin using dissolvable Doxorubicin-containing Microneedle arrays (D-MNA) representing ~$2 billion in potential market opportunityThe Company plans to complete patient recruitment for SKNJCT-003 before the end of Q4 2025 and to request End-of-Phase 2 (EOP2) with the FDA in Q1 2026

Maryland ASMFC Delegates Once Again Claim "No Menhaden" - But Baltimore Fish Kills Show Otherwise

WASHINGTON, D.C. / ACCESS Newswire / September 29, 2025 / For the second year in a row, Maryland's top delegates to the Atlantic States Marine Fisheries Commission (ASMFC) claimed menhaden were absent from Maryland's upper Chesapeake Bay, blaming Virginia's commercial fishermen for intercepting the fish. Yet within weeks of their irresponsible statements, tens of thousands of menhaden turned up dead in a series of massive fish kills in Baltimore Harbor, directly contradicting their testimony.

Hypha Labs and Automated Technical Services (ATS) Enter into Agreement to Scale its Mushroom Accelerator Technology for Commercial Nutraceutical Manufacturing

LAS VEGAS, NV / ACCESS Newswire / September 29, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the development of functional mushroom technologies, announced today that it has entered an agreement with Automated Technical Services to design and build a commercial-scale Mushroom Accelerator. This scaled-up system will produce Hypha's proprietary mushroom-based ingredients for sale to nutraceutical manufacturers worldwide.

BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization

VANCOUVER,BC / ACCESS Newswire / September 29, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery technologies, is pleased to provide an update on its proprietary Cladribine sublingual thin-film drug reformulation program (BNT23001), a next-generation delivery platform designed to improve bioavailability, patient adherence, and therapeutic outcomes in the treatment of neurological disorders, primarily multiple sclerosis (MS).

Angle PLC Announces Presentation of Data on Glioblastoma

CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma PatientsGBM CTC isolation only possible with Parsortix label-free methodologyData presented at the 7th ACTC meeting

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology

VANCOUVER, BC / ACCESS Newswire / September 29, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that Nucro-Technics Inc. ("Nucro-Technics"), a Toronto-based contract research organization working in collaboration with Onco to conduct preclinical and analytical development services (see press release July 4, 2025), has initiated laboratory work under the Company's Investigational New Drug (IND) enabling program. The focus of this first phase is to pursue development and validation of advanced analytical methods to measure Onco's exclusively licensed Polynucleotide Kinase Phosphatase (PNKP) inhibitor (the "Technology"), in both preclinical samples and drug formulations. These methods are a cornerstone of preclinical testing, ensuring that researchers can reliably track how the drug is processed in the body. Part of this effort will involve animal model testing, aimed at generating essential insights into how the compound is metabolized and distributed before advancing to clinical trials. In practical terms, this work establishes the essential analytical tools required by regulators as a necessary pre-condition to future human clinical trials.

Two dead after shooting, fire at US Mormon church

At least two people were killed and several others injured Sunday after a shooter targeted a Mormon church in Michigan, authorities said, in the latest deadly tragedy that US President Donald Trump called part of a national "epidemic of violence."

Two dead after US shooting, fire at Mormon church

At least two people were killed and several others injured Sunday after a shooter targeted a Mormon church in Michigan, authorities said, in the latest deadly tragedy that US President Donald Trump called part of a national "epidemic of violence."

Free Picasso park to open in Paris in 2030

A park featuring Picasso sculptures is to open to the public in central Paris in 2030, with free entry, the head of the city's Picasso Museum told AFP on Sunday.

Indian actor-politician's aides charged after rally stampede kills 40

Police charged three close aides of a popular actor and politician with culpable homicide and negligence on Sunday after a stampede at his rally in southern India killed at least 40 people, officials said.

Massive crowd, chaos preceded deadly India rally stampede

A stampede that killed dozens at a south India political rally happened after a crowd of thousands waited hours in baking heat without sufficient safeguards, officials and witnesses said Sunday.

President Trump Clears the Path for Medical Marijuana Reform - But Why Is DEA Attorney Aarathi Haig Still Practicing Law with Ethical Violations

"DEA has already admitted its tribunal system was unconstitutional. Yet dirty cops and unethical attorneys like Aarathi Haig are still in positions of power. Every day she remains, patients suffer - and it proves DEA reform is still just talk." - Duane Boise, CEO, MMJ International Holdings

Argentina protesters march for victims of live-streamed femicide

Thousands of protesters took to the streets of Buenos Aires on Saturday to demand justice for three young women whose torture and murders were live-streamed on social media, in a case that has shocked Argentina.

After Armani, Italian fashion houses are in flux

The first Milan Fashion Week without Giorgio Armani marks the end of an era in Italian luxury, at a time when houses across the sector are already in transition.

Philippines death toll rises to 11 as storm Bualoi bears down on Vietnam

The death toll from Severe Tropical Storm Bualoi rose to 11 in the Philippines on Saturday as the cyclone bore down on Vietnam, authorities said.

SCS	0.12%	16.14	$
CMSD	-0.4%	23.845	$
RBGPF	0.12%	82.5	$
GSK	6.52%	57.06	$
RIO	-1.2%	95.23	$
BCC	4.46%	88.893	$
BTI	-0.45%	61.595	$
NGG	2.01%	88	$
RYCEF	-2.1%	16.65	$
CMSC	-0.55%	23.53	$
AZN	1.41%	186.96	$
RELX	-1.87%	29.95	$
BCE	1.29%	26.44	$
JRI	0.14%	13.138	$
BP	1.27%	39.32	$
VOD	2.31%	15.61	$

Arizona Tribune - Boulevard (English)

Featured

German far-right MP detained over alleged Belarus sanctions breach

Starmer faces MPs as pressure grows over Mandelson scandal

Last news